Use Code: ND30 And Get 30% OFF | Get Free Delivery With No Minimum Order

Frequently bought together
Brand : SPASMOPAN
SPASMOPAN TAB
7.4
- Sku : I-006058
Key features
SPASMOPAN TAB is a tablet formulation containing hyoscine butylbromide 10 mg as the active ingredient. It acts as a peripherally acting antimuscarinic antispasmodic, competitively blocking muscarinic receptors on peripheral smooth muscle to reduce spasms, with minimal central nervous system penetration due to its quaternary ammonium structure. It is indicated for symptomatic relief of abdominal pain and cramps from gastrointestinal smooth‑muscle spasm and for spasm‑related biliary and urinary tract (renal) colic. Available in tablet form in packs of 20.- Brand: SPASMOPAN
- Active Ingredient: HYOSCINE BUTYLBROMIDE
- Strength: 10mg
- Dosage Form: Tablet
- Pack Size: 20 Tablets
- Route: Oral use
- Prescription Status: OTC
- Therapeutic Class: Alimentary Tract & Metabolism
- Drug Class: Peripherally acting antimuscarinic (anticholinergic) antispasmodic; quaternary ammonium compound.
- Manufacturer: The Arab Pharmaceutical Manufacturing PSC Sult
- Country of Origin: Jordan
- SFDA Registration No.: 3101221658
- Shelf Life: 36 months
- Storage: store below 25°c
- Gi Condition: IBS
Frequently bought together
Description
Indications
Approved Uses
Symptomatic relief of abdominal pain/cramps due to smooth‑muscle spasm of the gastrointestinal tract; spasm in the biliary tract (biliary colic) and urinary tract (renal colic).
Side Effects
Common Side Effects
Dry mouth, tachycardia/palpitations, reduced sweating, skin reactions (rash/urticaria/pruritus), urinary retention, anaphylactic reactions/shock.
Pharmacology
Mechanism of Action
Competitive antagonism at muscarinic (antimuscarinic) receptors in peripheral smooth muscle, reducing GI/biliary/urinary tract spasm; minimal CNS penetration due to quaternary ammonium structure.
Product Information
Composition per Dose
Each tablet: 10 mg hyoscine butylbromide
Generic Availability
Yes
Gi Condition
IBS
Reviewed by Al Mujtama Pharmacy Medical Review Team. Last reviewed 11-06-2026
-1744229570.gif)













